Antibe Therapeutics Net Worth 2014-2021 | ATBPF
Interactive chart of historical net worth (market cap) for Antibe Therapeutics (ATBPF) over the last 10 years. How much a company is worth is typically represented by its market capitalization, or the current stock price multiplied by the number of shares outstanding. Antibe Therapeutics net worth as of October 15, 2021 is $0.04B.
||Medical - Biomedical and Genetics
Antibe Therapeutics Inc. is a biotech company with a drug platform of therapeutics in pain and inflammation. Its lead drug candidate consists of ATB-346, non-addictive drug for chronic pain and inflammation; ATB-352, for a non-addictive analgesic for treating severe acute pain, while ATB-340 is a GI-safe derivative of aspirin. Antibe Therapeutics Inc. is based in Toronto, Canada.